Compare CADL & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | CRESY |
|---|---|---|
| Founded | 1999 | 1936 |
| Country | United States | Argentina |
| Employees | 55 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 739.2M | 804.3M |
| IPO Year | 2021 | 1997 |
| Metric | CADL | CRESY |
|---|---|---|
| Price | $9.92 | $11.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $21.75 | $15.86 |
| AVG Volume (30 Days) | ★ 1.1M | 288.8K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 5.26% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | $14.96 |
| Revenue Next Year | N/A | $19.02 |
| P/E Ratio | ★ N/A | $6.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | $8.91 |
| 52 Week High | $14.00 | $14.21 |
| Indicator | CADL | CRESY |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 43.38 |
| Support Level | $9.18 | $11.18 |
| Resistance Level | $10.59 | $11.74 |
| Average True Range (ATR) | 0.56 | 0.44 |
| MACD | -0.12 | -0.11 |
| Stochastic Oscillator | 15.26 | 15.91 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).